A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT04099979 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.
Conditions
- Psoriasis
- Psoriasis Vulgaris
- Psoriasis Universalis
- Psoriasis Face
- Psoriasis Nail
- Psoriatic Plaque
- Psoriasis Diffusa
- Psoriasis Punctata
- Psoriasis Palmaris
- Psoriasis Circinata
- Psoriasis Annularis
- Psoriasis Genital
- Psoriasis of Scalp
- Psoriasis Geographica
Interventions
- OTHER
-
No Intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis
NCT01045395 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients
NCT03807453 ·Status: COMPLETED
-
Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients
NCT02576197 ·Status: COMPLETED ·Phase: NA
-
Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin
NCT03584360 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis
NCT04439526 ·Status: COMPLETED
-
INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis
NCT05971992 ·Status: COMPLETED ·Phase: NA
-
The Role of Food Sensitivity in Psoriasis
NCT03084146 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
NCT00563524 ·Status: COMPLETED ·Phase: PHASE1
-
Modified Intermittent Fasting in Psoriasis
NCT04418791 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis
NCT02271971 ·Status: COMPLETED ·Phase: NA
-
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept
NCT00992394 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis
NCT01149252 ·Status: TERMINATED ·Phase: PHASE4
-
Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
NCT00427609 ·Status: TERMINATED ·Phase: PHASE2
-
Genetic Analysis of Pediatric Psoriasis
NCT03768284 ·Status: COMPLETED
-
Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current
NCT01765985 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effectiveness of Lower Cyclosporine Doses for Psoriasis
NCT00377325 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
NCT02274792 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
NCT07194200 ·Status: RECRUITING ·Phase: PHASE2
-
CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study
NCT06050330 ·Status: COMPLETED ·Phase: NA
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
CP-690-550 Ointment For Chronic Plaque Psoriasis
NCT01246583 ·Status: COMPLETED ·Phase: PHASE2